The company currently holds 18.54
M in liabilities with Debt to Equity (D/E) ratio of 1.28, which is about average as compared to similar companies. Xtant Medical Holdings has a current ratio of 1.2, suggesting that it may not have the ability to pay its financial obligations when due.
On a scale of 0 to 100, Xtant Medical holds a
performance score of 2. The firm maintains a market beta of 3.8189, which attests to a somewhat significant risk relative to the market. Let's try to break down what Xtant's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Xtant Medical will likely underperform. Although it is vital to follow
Xtant Medical Holdings historical
price patterns, it is good to be conservative about what you can do with the information regarding equity current price history. The philosophy towards determining
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. We have found twenty-seven
technical indicators for Xtant Medical Holdings, which you can use to evaluate the performance of the company. Please utilizes Xtant Medical Holdings
total risk alpha, as well as the
relationship between the downside variance and
daily balance of power to make a quick decision on whether Xtant Medical Holdings historical returns will revert.
Volatility is a rate at which the price of Xtant Medical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Xtant Medical may increase or decrease. In other words, similar to Xtant's
beta indicator, it measures the risk of Xtant Medical and helps estimate the fluctuations that may happen in a short period of time. So if prices of Xtant Medical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility. Please read more on our
technical analysis page.
Watch out for price decline
Please consider monitoring Xtant Medical on a daily basis if you are holding a position in it. Xtant Medical is trading at a penny-stock level, and the possibility of delisting is much higher compared to other stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion.
Most exchanges require public instruments, such as Xtant Medical stock to be traded above the $1 level to remain listed. If Xtant Medical stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How important is Xtant Medical's Liquidity
Xtant Medical
financial leverage refers to using borrowed capital as a funding source to finance Xtant Medical Holdings ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Xtant Medical financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Xtant Medical's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Xtant Medical's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the
breakdown between Xtant Medical's total debt and its cash.
Xtant Medical Gross Profit
Xtant Medical Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Xtant Medical previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Xtant Medical Gross Profit growth over the last 10 years. Please check Xtant Medical's
gross profit and other
fundamental indicators for more details.
Xtant Medical Volatility Drivers
Xtant Medical unsystematic risk is unique to Xtant Medical Holdings and usually not directly affected by the market or economic environment. An example of unsystematic risk is the possibility of poor earnings or a layoff due to coronavirus. One may mitigate nonsystematic risk by buying different securities in the same industry or by buying in different sectors. For example, if you have a position in Xtant Medical you can also buy
National Research Corp. You can also mitigate this risk by investing in the health care sector as well as in companies having nothing to do with it. This type of risk is also called diversifiable risk and can be understood from analyzing Xtant Medical important indicators over time. Here we run a correlation analysis between relevant fundamental ratios over at least ten year period to find a relationship in the way they react to changes in Xtant Medical income statement and balance sheet. Here are more
details about Xtant volatility.
Click cells to compare fundamentals
Breaking it down a bit more
The newest price gain of Xtant Medical Holdings may raise some interest from private investors as it is trading at a share price of
1.59 on
229,061 in trading volume. The company executives may have good odds in positioning the company resources to exploit market volatility in
June. The stock standard deviation of daily returns for 90 days investing horizon is currently 17.13. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Xtant Medical Holdings partners.
| 2014 | 2015 | 2020 | 2021 (projected) |
Interest Expense | 5.66 M | 7.73 M | 6.96 M | 7.51 M | Gross Profit | 22.3 M | 39.08 M | 35.17 M | 37.95 M |
Xtant Medical newest price drop can leaving private investors with little time to react
The treynor ratio is down to 0.25 as of today. Xtant Medical Holdings is displaying above-average volatility over the selected time horizon. Investors should scrutinize Xtant Medical Holdings independently to ensure intended market timing strategies are aligned with expectations about Xtant Medical volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Xtant Medical's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Xtant Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Final Take On Xtant Medical
Whereas some firms within the medical devices industry are still a little expensive, even after the recent corrections, Xtant Medical may offer a potential longer-term growth to private investors. To summarize, as of the 11th of May 2021, our ongoing 90 days buy-sell recommendation on the firm is
Strong Sell. We believe Xtant Medical is
overvalued with
low chance of bankruptcy for the next two years.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Xtant Medical Holdings. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com